Researchers have been excited about the medication , a novel dual agonist showing remarkable outcomes in initial trials for size loss . It functions by impacting two hormones : GLP-1 and GIP, that , when https://hassanbhvi202411.review-blogger.com/62355715/a-new-prospect-for-size-reduction